Related Experiment Video
Updated: Aug 11, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
New strategies for the treatment of type 2 diabetes
1University of Washington, Seattle 98195-6426, USA.
Abstract:
This review of current developments in the treatment of type 2 diabetes focuses on the achievement of normoglycemia through appropriately defined goals of diet, exercise, and drug therapy. Clinical nutritionists are central partners in the management of type 2 diabetes, and nutrition therapy is still considered the first-line therapy of choice. A nutritionist's role in the treatment at type 2 diabetes is to ensure an individualized, nutritionally adequate diet for patients, uncomplicated by episodes of hypoglycemia. In this role, clinical nutritionists must be aware of potential drug interactions with diet therapy and may be able to provide essential feedback about possible drug interactions to other members of the health care team, including nurses, pharmacists, and physicians. The role of insulin in treating type 2 diabetes is reexamined in the light of newly available oral antidiabetic agents and increasing awareness of the importance of insulin resistance and hyperinsulinemia in the development of diabetes complications. Because many patients use insulin to reduce blood glucose and glycated hemoglobin (HbA1c) to acceptable levels, management should combine diet therapy with insulin and/or 1 or 2 oral antidiabetic agents to help minimize the dose of exogenous insulin needed for glucose control.
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
